Ian Henderson

Title: Ian Henderson: Innovator in Pharmaceutical Science

Introduction

Ian Henderson is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative treatments for various medical conditions. With a total of 3 patents to his name, Henderson's work is recognized for its potential impact on healthcare.

Latest Patents

Henderson's latest patents include groundbreaking research on glucagon receptor antagonists. These patents provide solid state forms of compounds, including enantiomerically pure forms and pharmaceutically acceptable salts or co-crystals. The research focuses on pharmaceutical compositions and methods for treating conditions such as Type I and II diabetes, insulin resistance, hyperglycemia, ketoacidosis, and ketosis. Another significant patent involves methods for treating disorders associated with glomerular function, utilizing a biphenyl sulfonamide compound that acts as a dual angiotensin and endothelin receptor antagonist.

Career Highlights

Ian Henderson is currently employed at Ligand Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving patient outcomes through innovative pharmaceutical solutions.

Collaborations

Henderson collaborates with esteemed colleagues, including Jinkun Zhang and Zofia E Dziewanowska. These partnerships enhance the scope and impact of his research, fostering a collaborative environment that drives innovation.

Conclusion

Ian Henderson's contributions to pharmaceutical science exemplify the importance of innovation in addressing complex medical challenges. His patents and ongoing research hold promise for improving treatment options for patients worldwide.